TL;DR
Healthcare marketing materials in Ireland must satisfy multiple overlapping regulations, including HPRA enforcement rules, the IPHA Code of Practice (updated June 2025), and ASAI advertising standards. Agencies like MedMedia, Agency X, and consultancies like Aureum Pharma offer compliance-ready capabilities, with Veeva PromoMats certification being a key differentiator. Choosing the right agency means looking beyond creative talent to regulatory fluency, MLR workflow integration, and specific knowledge of Irish (not UK) compliance requirements.
Why “Compliance-Ready” Matters More Than You Think
If you work in healthcare or pharma marketing in Ireland, you already know the stakes. A promotional piece that passes internal review in London can still violate Irish law. A digital ad missing fair balance language can trigger enforcement action. And a submission that arrives at your Medical, Legal, Regulatory (MLR) team with unannotated claims can delay a campaign by weeks or months.
The question of which agencies offer compliance-ready marketing materials for healthcare in Ireland is not just about finding a good creative partner. It’s about finding one that understands the regulatory architecture well enough to build compliant materials from the first draft, not just fix them at the final approval stage.
Penalties for non-compliant healthcare advertising in Ireland are severe: up to €120,000 in fines and 10 years’ imprisonment on indictment, with subsequent convictions raising the ceiling to €300,000. The HPRA recently instructed 135 clinics to remove unlawful botulinum toxin advertising, demonstrating that enforcement is active, not theoretical.
This guide covers the regulatory bodies, key terminology, agency options, and practical evaluation criteria that healthcare marketers in Ireland need to commission materials with confidence.
Explore our healthcare marketing services to see how strategic foundations support compliant campaigns.
Regulatory Bodies and What They Control
Understanding which agencies offer compliance-ready marketing materials for healthcare in Ireland starts with understanding who sets the rules. There are five primary bodies, each with different scope and enforcement powers.
HPRA (Health Products Regulatory Authority)
The HPRA is the statutory body responsible for monitoring and enforcing advertising regulations for medicinal products in Ireland. It operates under the Medicinal Products (Control of Advertising) Regulations 2007 (S.I. No. 541 of 2007), which implement EU Directive 2001/83/EC. The HPRA revised its Guide to Advertising Compliance in March 2025, with notable changes to digital advertising provisions.
Why it matters for agency selection: Any agency producing materials for medicinal products needs to know this guide inside out. The March 2025 revision tightened requirements around online promotion, including the balance of safety and efficacy information in digital ads. Simply linking to the Summary of Product Characteristics (SmPC) is no longer considered sufficient on its own.
IPHA (Irish Pharmaceutical Healthcare Association)
IPHA administers two self-regulatory codes: the Code of Practice for the Pharmaceutical Industry and the Self-Care Advertising Code. The Revised Pharmaceutical Code V8.6 became effective 1 June 2025. This is the code that most directly shapes how pharma companies and their agency partners create promotional materials.
A critical change in V8.6: the code now explicitly extends compliance obligations to third parties working on a company’s behalf, including “advertising companies, business consultants, market research companies” and joint venture partners. This means an agency that produces your materials shares your compliance burden.
ASAI (Advertising Standards Authority for Ireland)
The ASAI administers the Code of Standards for Advertising and Marketing Communications in Ireland (7th Edition). While it covers all advertising, its health and beauty provisions are directly relevant to healthcare marketers. The ASAI specifically prohibits the advertisement of prescription-only medicines to the public.
Coimisiún na Meán
Ireland’s media regulator produced the Online Safety Code in October 2024, which affects how healthcare content appears on digital platforms. While less directly focused on pharma, it adds another compliance layer for digital campaigns.
Medicines for Ireland
Formerly the Irish Generics Medicines Association (IGMA), this body publishes its own Code of Practice on Advertising of Medicinal Products. Generic pharma companies need to comply with this code alongside HPRA regulations.
Key Legislation and Codes of Practice
Healthcare marketing in Ireland sits at the intersection of multiple legal frameworks. Here’s what your agency needs to navigate.
S.I. No. 541 of 2007 is the principal legislation. It governs all advertising of medicinal products and implements EU Directive 2001/83/EC into Irish law. Prescription-only medicines, controlled drugs, and certain non-prescription products cannot be advertised to the general public.
The IPHA Code V8.6 requires that a scientific service, which must include a doctor or pharmacist, approves all promotional material before release. It prohibits exaggerated claims. A product cannot be called “new” if it has been available in Ireland for more than 12 months. The word “safe” must always be qualified.
One rule catches many companies off guard: promotional material must not state or imply approval by the HPRA or the European Medicines Agency. This is a common mistake in materials adapted from other markets.
Medicines vs. Medical Devices: A Critical Distinction
The HPRA advertising guide does not apply to medical devices. Devices follow a separate regulatory pathway under the EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). Any medical device being advertised must carry a CE mark. Most content conflates these two categories, but the compliance requirements are fundamentally different.
This distinction matters when evaluating agencies. An agency experienced in pharma promotion may not understand medical device requirements, and vice versa. For medtech companies, this is a selection criterion worth testing early. We explored this challenge in our work on medtech go-to-market strategy with Arrotek, where segmented messaging for different buyer types required careful attention to regulatory boundaries.
Essential Compliance Terminology: The Glossary
This section defines the terms that healthcare marketers encounter when commissioning compliance-ready materials. Each definition explains why the concept matters in practical terms, particularly when briefing or evaluating an agency.
Compliance-Ready Marketing Materials
Materials that arrive at internal MLR review with all necessary elements already in place: claims linked to approved labelling or SmPC data, mandatory prescribing information formatted correctly, adverse event reporting statements included, fair balance between benefit and risk maintained, references annotated, and audit trail documentation prepared.
No ranking page in search results currently defines this term. In practice, “compliance-ready” means an agency builds regulatory requirements into the creative process from the start, not as a final check before submission. Practitioners on LinkedIn have noted that poorly prepared submissions create cascading delays. As one senior project manager shared, “An error-free and well-prepared submission is pivotal in expediting the review process. I’ve seen examples of poorly prepared submissions, which end up delaying the ‘go live’ dates.”
MLR Review (Medical, Legal, Regulatory)
The internal review process where medical, legal, and regulatory teams evaluate promotional materials before release. At mid-to-large pharma companies, MLR review cycles commonly stretch to 50 to 60 days per content piece. In the European market, the average is closer to 20 days.
Why it matters: If your agency doesn’t understand MLR timelines, they’ll promise delivery dates they can’t keep. Agencies experienced in healthcare plan assets months in advance. If an agency only talks about compliance at the final approval stage, that’s a red flag.
SmPC (Summary of Product Characteristics)
The SmPC is the approved document that describes a medicinal product’s properties and conditions for use. Every promotional claim must trace back to the SmPC or approved labelling. An agency producing compliance-ready materials needs to work directly from the SmPC when writing copy, not from marketing briefs alone.
Fair Balance
The regulatory requirement to present a product’s benefits and risks proportionally. This applies across all formats, from detail aids to digital banners. The HPRA’s March 2025 update specifically reinforced that digital advertisements must maintain fair balance, even in limited-space formats.
Promotional vs. Non-Promotional Materials
The HPRA draws a clear line between these categories. Promotional materials (detail aids, branded emails, HCP websites) carry full regulatory obligations. Non-promotional materials (disease awareness booklets, unbranded patient education) have different requirements. Treating a non-promotional piece as promotional, or vice versa, creates legal exposure. This is a classification error that agencies unfamiliar with Irish regulations commonly make.
Disease Awareness Campaigns
Campaigns that educate the public about a condition without naming a specific product. These are exempt from some advertising restrictions but still must not cross the line into implicit product promotion. For healthcare companies, disease awareness is also a significant organic search opportunity, where SEO and compliance requirements need to work together.
Veeva PromoMats
The dominant content management platform used across the pharmaceutical industry for creating, reviewing, approving, and distributing promotional materials. PromoMats automatically versions documents, maintains prior versions, and logs every action (who reviewed, who approved or rejected, when) to create a complete compliance record. Electronic signatures can be required at approval steps.
Why it matters for Ireland: The IPHA Code V8.6 now extends compliance obligations to agencies. Any agency claiming to produce compliance-ready materials should be fluent in Veeva PromoMats, because the audit trail it creates is how compliance is documented and proven.
Claims Library
A centralized, pre-approved collection of marketing claims that have been reviewed against the SmPC and cleared through MLR. Agencies that work from a claims library produce materials that move through review faster because every statement has already been validated.
Modular Content
A content strategy where materials are built from pre-approved, reusable components rather than created from scratch each time. This approach reduces MLR burden, improves consistency, and shortens timelines. For organizations managing multiple products or markets, modular content is increasingly the standard approach.
Transfer of Value
The disclosure requirement for payments, gifts, or other benefits provided to healthcare professionals (HCPs) or healthcare organizations (HCOs). This affects conference sponsorship, speaker fees, educational grants, and similar interactions. Agencies managing events or conference materials need to understand these obligations.
CE Marking
The conformity marking required for medical devices sold in the EU. Any medical device advertisement must reference a product that carries valid CE marking. This is separate from the medicinal product framework and follows the MDR/IVDR pathway.
Agencies and Service Providers Active in Irish Healthcare Compliance
When researching which agencies offer compliance-ready marketing materials for healthcare in Ireland, four names surface consistently across regulatory directories, client references, and industry listings.
MedMedia (medmedia.ie)
Established in 1995 as a specialist agency for pharmaceutical and healthcare sectors, MedMedia has become Ireland’s first and only Veeva-certified digital agency. Their client roster includes Novartis, AbbVie, Roche, and Astellas. A Lundbeck brand manager publicly praised their ability to deliver work “in our highly regulated environment.” Veeva certification is a meaningful differentiator because it means the agency has been formally verified to work within the platform’s compliance workflow.
Agency X (agencyx.ie)
Agency X has worked extensively with IPHA Code compliance and Veeva PromoMats. Many of their pharma clients have been with them for a decade or more, which speaks to the depth of regulatory knowledge accumulated through long-term relationships. They offer campaign strategy, brand creative, and events (in-person, hybrid, and online) across both traditional and digital channels.
Aureum Pharma (aureumpharma.ie)
Not a marketing agency in the traditional sense, Aureum Pharma is a pharma consultancy with 25 years of experience in the Irish healthcare ecosystem. They specifically offer promotional and non-promotional material sign-off via Veeva PromoMats, positioning them as a compliance partner rather than a creative one. For companies that need help with the regulatory review process itself, Aureum fills a gap that creative agencies don’t.
PharmaLex (pharmalex.com)
A global provider focused on promotional material review and validation for drugs and medical devices. PharmaLex serves as a strategic partner for companies managing compliance across multiple markets, including Ireland. Their strength is international congress materials and multi-market compliance, though they’re less focused on Ireland-specific creative production.
Directory-Listed Agencies
The Clutch.co directory lists several agencies under healthcare digital marketing in Ireland, including CEEK, M3.agency, Ninja Promo, e intelligence, UpMedico, and SWOT Digital. None of these specifically advertise compliance-ready pharma material creation on their profiles, making due diligence essential before engagement.
The Strategic and Brand Layer
There’s a distinction worth drawing between agencies that handle the regulatory sign-off process and those that build the strategic foundations (brand positioning, messaging frameworks, visual identity, commercial growth strategy) that compliance-ready materials depend on. The best outcomes happen when upstream brand strategy is built with regulatory constraints already factored in.
CSM Agency’s work with Medentech illustrates this approach: creating compliance-ready sales materials for pharma distributors across Southeast Asia, where simplified ABM decks had to work across language barriers while maintaining regulatory integrity. Similarly, their healthcare website and booking system work for Centric Health, Ireland’s largest GP network, required deep understanding of how regulated healthcare organizations communicate with patients.
What Makes an Agency “Compliance-Ready”?
Knowing which agencies offer compliance-ready marketing materials for healthcare in Ireland requires a clear evaluation framework. Here’s what to test for.
IPHA Code Fluency
Since June 2025, the IPHA Code V8.6 explicitly requires third-party agencies to comply with its provisions. Ask the agency directly: do they train their teams on the IPHA Code? Can they cite specific requirements? An agency that references the ABPI Code (the UK equivalent) but not the IPHA Code is operating from the wrong playbook.
The UK Is Not Ireland
This is the single most common compliance error for multinational companies. IPHA explicitly warns that the ABPI Code does not guarantee compliance with Irish regulatory requirements. Companies managing Ireland and UK campaigns from a London office need an agency that understands both frameworks and can articulate the differences. The regulatory structures, enforcement mechanisms, and specific rules diverge in ways that matter.
Veeva PromoMats Integration
Any agency producing pharma promotional materials should demonstrate working knowledge of Veeva PromoMats. This means understanding version control, approval workflows, electronic signatures, and audit trail requirements. Agencies that produce materials outside the Veeva ecosystem create unnecessary rework and compliance risk.
MLR-Aware Planning
Ask how far in advance the agency plans content. If the answer is 4 to 6 weeks, they don’t understand pharma timelines. Experienced healthcare agencies plan assets many months ahead, building regulatory review time into the project schedule from the outset.
Ireland-Specific Track Record
Request case studies or client references specifically in the Irish market. Global agencies with pharma experience may still lack knowledge of HPRA enforcement patterns, ASAI rulings, or the practical workings of the IPHA complaint process.
Modular Content Capability
Agencies that build materials from pre-approved modular components help reduce MLR bottlenecks. This is increasingly important as pharma companies manage more channels, more markets, and tighter timelines.
Book a consultation to discuss how strategic brand and messaging foundations can support your compliance-ready materials.
Types of Healthcare Marketing Materials Subject to Compliance
Understanding the full scope of regulated materials helps when briefing agencies. These are the primary formats that fall under Irish healthcare advertising rules.
Detail aids and sales presentations remain the backbone of HCP-directed promotion. Every claim, image, and graph must be traceable to the SmPC. Agencies experienced in this format know that even the font size of prescribing information is subject to scrutiny.
Digital banner advertisements face specific constraints. The HPRA’s March 2025 update addressed limited-space formats, requiring fair balance even where character counts are tight. This is a design challenge as much as a regulatory one.
HCP-facing websites and email campaigns must be restricted to persons qualified to prescribe or supply. Access controls, disclaimers, and prescribing information requirements apply.
Patient information booklets follow different rules depending on whether they’re classified as promotional or non-promotional. The classification determines the level of review required and the mandatory information included.
Exhibition materials and conference stands carry the same compliance obligations as printed materials, with additional Transfer of Value considerations for any hospitality or sponsorship elements.
Social media content is where confusion runs highest. Social media can only be used to promote prescription-only medicines if the audience is restricted to qualified prescribers or suppliers. The ASAI Code reinforces this prohibition for public-facing channels.
For companies managing distributor enablement across multiple markets, the challenge compounds. Localised materials must satisfy both Irish compliance standards and the regulatory requirements of each destination market.
Common Compliance Pitfalls
These are the errors that most frequently cause delays, enforcement action, or MLR rejections in Irish healthcare marketing.
Assuming UK ABPI compliance covers Ireland. It does not. The IPHA has stated this explicitly. Materials approved under ABPI rules may still violate Irish regulations.
Using the word “safe” without qualification. The IPHA Code requires that safety claims be qualified with appropriate context. Unqualified use of “safe” will be rejected at MLR review.
Calling a product “new” after 12 months. The IPHA Code sets a clear 12-month window. After that, the “new” designation must be removed from all materials.
Omitting adverse event reporting statements. Every promotional piece must include information about how adverse events should be reported. This is a mandatory element, not an optional addition.
Failing to extend compliance training to agency partners. Under the IPHA Code V8.6, companies are responsible for ensuring their agencies comply. An untrained agency creates direct liability for the sponsoring company.
Claiming or implying HPRA or EMA endorsement. Promotional material must not state or suggest regulatory authority approval. This includes subtle implications through logo placement or language choices.
Non-IPHA members assuming the code doesn’t apply. The IPHA Code has been endorsed by the Minister for Health. Non-members should strongly consider complying, as the code is treated as the benchmark for acceptable conduct regardless of membership status.
How to Evaluate and Brief an Agency
When evaluating which agencies offer compliance-ready marketing materials for healthcare in Ireland, structure your assessment around these questions.
During selection:
Can the agency name the specific Irish regulations governing your product category (medicinal vs. medical device)?
Do they have Veeva PromoMats experience, and at what level (basic use vs. certification)?
What is their typical content planning lead time for regulated materials?
Can they provide Irish healthcare client references (not just global pharma experience)?
How do they handle the claims annotation process?
Red flags to watch for:
The agency mentions compliance only when discussing final review or approval
They reference UK regulations without distinguishing Irish requirements
They can’t explain the difference between promotional and non-promotional classifications
Their planning timelines don’t account for MLR review cycles
During the brief:
Provide your SmPC and claims library upfront
Clarify whether materials are promotional or non-promotional
Specify target audience (HCP, pharmacist, patient, general public)
Share your Veeva PromoMats workflow and access requirements
Define the mandatory elements (prescribing information format, adverse event statements, fair balance requirements)
For companies that need to build or refine brand strategy and positioning before commissioning tactical materials, getting the strategic foundations right first saves significant time and rework downstream.
Frequently Asked Questions
Can prescription medicines be advertised in Ireland?
No. Prescription-only medicines, controlled drugs, and certain non-prescription medicinal products cannot be advertised to the general public. Promotion of prescription medicines is restricted to healthcare professionals qualified to prescribe or supply them.
What is the difference between IPHA and HPRA?
The HPRA is the statutory regulator with legal enforcement powers under S.I. 541/2007. It can prosecute non-compliant advertisers. IPHA is an industry self-regulatory body that administers voluntary codes of practice. Both set rules that affect healthcare marketing, but only the HPRA can impose criminal penalties.
Do compliance rules apply to digital and social media?
Yes. The HPRA revised its advertising compliance guide in March 2025 to specifically address online promotion, including requirements around fair balance in digital formats. Social media can only be used to promote prescription-only medicines to qualified healthcare professionals, not the general public. The ASAI Code reinforces this restriction.
What penalties exist for non-compliant healthcare advertising in Ireland?
Summary conviction can result in fines up to €2,500 and/or 12 months’ imprisonment. Conviction on indictment carries fines up to €120,000 and/or 10 years’ imprisonment. Subsequent convictions can result in fines up to €300,000.
Does the IPHA Code apply to non-members?
The Code has been endorsed and approved by the Minister for Health. While technically a self-regulatory instrument, non-IPHA members should strongly consider compliance because the code serves as the industry benchmark and regulators reference it during enforcement actions.
Is Veeva PromoMats required for compliance in Ireland?
It’s not legally mandated, but Veeva PromoMats is the dominant platform used across the pharma industry for promotional material review and approval. Its audit trail, version control, and electronic signature capabilities make it the practical standard for demonstrating compliance.
Can I use UK-approved materials in Ireland without changes?
No. IPHA explicitly warns that compliance with UK ABPI codes does not guarantee compliance with Irish regulatory requirements. Materials must be reviewed and potentially adapted for the Irish market, even if they’ve been approved in the UK.
Are medical devices subject to the same advertising rules as medicines?
No. Medical devices and medicines follow different regulatory pathways. The HPRA advertising guide applies to medicinal products, not medical devices. Devices must comply with the EU Medical Devices Regulation and carry CE marking. Most agencies specialise in one category or the other, so confirm which pathway applies to your products before engaging a partner.